WebMD

Zoryve: FDA Expands Use of Once-Daily Steroid-Free Skin Cream for Children Ages 2-5 Years With Mild to Moderate Eczema

Zoryve (roflumilast) cream is a prescription steroid-free medicine for treating inflammatory skin conditions such as atopic dermatitis (eczema) and plaque psoriasis. Zoryve works by blocking an enzyme ...
Monthly Prescribing Reference

Zoryve Cream 0.05% Approved for Atopic Dermatitis in 2- to 5-Year-Olds

Credit: Acrutis. Zoryve cream 0.05% is a once-daily, steroid-free cream for atopic dermatitis in patients aged 2 to 5 years. Zoryve cream 0.05% is expected to be available by the end of October 2025.
9to5google

Google launches Gemini 2.5 Pro, free app access continues

Following the first preview three months ago, Google is ready to launch Gemini 2.5 Pro and make the reasoning model generally available (GA) for consumers and developers. With this launch, 2.5 Pro ...
The Lancet

Gaps in the management of adrenal insufficiency in melanoma survivors: a retrospective cohort study

bDepartment of Endocrinology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, FuZhou, Fujian, PR China ...
The Lancet

Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double ...

iDepartment of Dermatology, University Hospital of Centre of Paris, Cochin Hospital, AP-HP, Paris, France jDepartment of Occupational and Environmental Diseases, University Hospital of Centre of Paris ...
BioSpace

ANI Pharma Announces Launch Of Hydrocortisone Rectal Cream 1% And 2.5%

BAUDETTE, Minn., April 5, 2016 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the commercial launch of 1% and 2.5% hydrocortisone cream for rectal use. The combined ...